AVITA Medical, Inc.
RCEL
$9.91
-$0.15-1.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 75.63M | 72.35M | 71.61M | 72.40M | 74.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.63M | 72.35M | 71.61M | 72.40M | 74.88M |
| Cost of Revenue | 13.95M | 13.48M | 12.79M | 11.77M | 11.77M |
| Gross Profit | 61.68M | 58.86M | 58.82M | 60.63M | 63.11M |
| SG&A Expenses | 76.75M | 78.19M | 80.51M | 82.72M | 88.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 110.85M | 111.86M | 114.15M | 114.49M | 121.62M |
| Operating Income | -35.22M | -39.51M | -42.54M | -42.09M | -46.74M |
| Income Before Tax | -43.06M | -45.35M | -48.58M | -48.51M | -51.57M |
| Income Tax Expenses | 20.00K | -9.00K | 10.00K | 46.00K | 3.00K |
| Earnings from Continuing Operations | -43.08 | -45.34 | -48.59 | -48.56 | -51.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.08M | -45.34M | -48.59M | -48.56M | -51.57M |
| EBIT | -35.22M | -39.51M | -42.54M | -42.09M | -46.74M |
| EBITDA | -32.77M | -37.11M | -40.24M | -40.03M | -44.95M |
| EPS Basic | -1.44 | -1.57 | -1.75 | -1.81 | -1.97 |
| Normalized Basic EPS | -0.87 | -0.92 | -1.02 | -1.07 | -1.17 |
| EPS Diluted | -1.44 | -1.57 | -1.75 | -1.81 | -1.97 |
| Normalized Diluted EPS | -0.87 | -0.92 | -1.02 | -1.07 | -1.17 |
| Average Basic Shares Outstanding | 120.07M | 115.69M | 111.40M | 107.16M | 104.75M |
| Average Diluted Shares Outstanding | 120.07M | 115.69M | 111.40M | 107.16M | 104.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |